Showing results (1341-1350 of 7,887) with videos related to

Sort By:
Pageof 789
Eye (London, England)|July 11, 2024
Real world treatment outcomes in polypoidal choroidal vasculopathy in a Caucasian population of British ethnicityGabriella De Salvo, Suresh Thulasidharan, Ramez Barbara, et al.
Eye (London, England)|July 27, 2024
An artificial intelligence platform for the screening and managing of strabismusDawen Wu, Yanfei Li, Haixian Zhang, et al.
Eye (London, England)|July 27, 2024
Incidence and outcomes of post-operative endophthalmitis following elective phacoemulsification cataract surgery, between 2015 and 2022Magdalene Y L Ting, Giulio Pocobelli, Diana M Butu, et al.
Eye (London, England)|July 28, 2024
Spontaneous suprachoroidal haemorrhage: clinical features, visual outcomes and prognosis factorsRodrigo Anguita, Janice Roth, Lorenzo Ferro Desideri, et al.
Eye (London, England)|July 4, 2024
Robotising vitreoretinal surgeriesHelen Mi, Robert E MacLaren, Jasmina Cehajic-Kapetanovic
Eye (London, England)|July 4, 2024
Real world efficacy and durability of faricimab in patients with neovascular AMD (nAMD) who had sub-optimal response to prior anti-VEGF therapyChristine Goodchild, Clare Bailey, Jimena Soto Hernaez, et al.
Eye (London, England)|August 28, 2024
Fibrosis in age-related neovascular macular degeneration in the anti-VEGF eraBeatriz G Armendariz, Usha Chakravarthy
Eye (London, England)|September 3, 2024
Costs and cost-effectiveness of the Kerala pilot screening programme for diabetic retinopathy in the public health systemRaphael Wittenberg, Robert Anderson, Stuart Redding, et al.
Eye (London, England)|June 10, 2024
Oculomics analysis in multiple sclerosis: Current ophthalmic clinical and imaging biomarkersAlex Suh, Gilad Hampel, Aditya Vinjamuri, et al.
Eye (London, England)|May 28, 2024
ROBIN: a randomised, double-masked, placebo-controlled Phase IIa study of the AOC3 inhibitor BI 1467335 in diabetic retinopathyQuan Dong Nguyen, Justis P Ehlers, David S Boyer, et al.
Pageof 789